JP2013539454A5 - - Google Patents

Download PDF

Info

Publication number
JP2013539454A5
JP2013539454A5 JP2013519096A JP2013519096A JP2013539454A5 JP 2013539454 A5 JP2013539454 A5 JP 2013539454A5 JP 2013519096 A JP2013519096 A JP 2013519096A JP 2013519096 A JP2013519096 A JP 2013519096A JP 2013539454 A5 JP2013539454 A5 JP 2013539454A5
Authority
JP
Japan
Prior art keywords
seq
antibody
dnnnnrps
afiwydgsnkyyadsvkgr
arysgwyfdy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013519096A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013539454A (ja
JP5992406B2 (ja
Filing date
Publication date
Priority claimed from GBGB1011771.1A external-priority patent/GB201011771D0/en
Application filed filed Critical
Publication of JP2013539454A publication Critical patent/JP2013539454A/ja
Publication of JP2013539454A5 publication Critical patent/JP2013539454A5/ja
Application granted granted Critical
Publication of JP5992406B2 publication Critical patent/JP5992406B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

JP2013519096A 2010-07-13 2011-07-13 再発した癌患者の治療におけるｉｃａｍ−１に対する抗体の使用 Expired - Fee Related JP5992406B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1011771.1 2010-07-13
GBGB1011771.1A GB201011771D0 (en) 2010-07-13 2010-07-13 Biological material and particular uses thereof
PCT/EP2011/061983 WO2012007516A1 (en) 2010-07-13 2011-07-13 Use of antibodies against icam-1 in the treatment of patients with relapsed cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016074000A Division JP2016175906A (ja) 2010-07-13 2016-04-01 再発した癌患者の治療におけるｉｃａｍ−１に対する抗体の使用

Publications (3)

Publication Number Publication Date
JP2013539454A JP2013539454A (ja) 2013-10-24
JP2013539454A5 true JP2013539454A5 (enExample) 2014-03-20
JP5992406B2 JP5992406B2 (ja) 2016-09-14

Family

ID=42712312

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013519096A Expired - Fee Related JP5992406B2 (ja) 2010-07-13 2011-07-13 再発した癌患者の治療におけるｉｃａｍ−１に対する抗体の使用
JP2016074000A Pending JP2016175906A (ja) 2010-07-13 2016-04-01 再発した癌患者の治療におけるｉｃａｍ−１に対する抗体の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016074000A Pending JP2016175906A (ja) 2010-07-13 2016-04-01 再発した癌患者の治療におけるｉｃａｍ−１に対する抗体の使用

Country Status (10)

Country Link
US (2) US20130189260A1 (enExample)
EP (1) EP2593481A1 (enExample)
JP (2) JP5992406B2 (enExample)
KR (1) KR20130100977A (enExample)
CN (1) CN103003308B (enExample)
AU (1) AU2011278350B2 (enExample)
CA (1) CA2805200A1 (enExample)
GB (1) GB201011771D0 (enExample)
RU (1) RU2593709C2 (enExample)
WO (1) WO2012007516A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525214D0 (en) 2005-12-12 2006-01-18 Bioinvent Int Ab Biological materials and uses thereof
GB2495113A (en) * 2011-09-29 2013-04-03 Bioinvent Int Ab Anti-ICAM-1 antibody for treating multiple-myeloma-related disorders
HK1215174A1 (zh) 2012-11-29 2016-08-19 Bayer Healthcare Llc 針對活化蛋白c的人源化單克隆抗體及其用途
CN104812402A (zh) * 2012-11-29 2015-07-29 拜尔健康护理有限责任公司 针对活化蛋白C (aPC)的单克隆抗体
GB201300346D0 (en) * 2013-01-09 2013-02-20 Biolnvent Internat Ab BiologIcal materials and uses thereof
WO2015148971A2 (en) 2014-03-27 2015-10-01 Research Foundation Of The City University Of New York Method for detecting or treating triple negative breast cancer
KR101674874B1 (ko) 2014-10-21 2016-11-22 한국원자력의학원 항암제 내성 예측용 바이오마커로서의 ｉｃａｍ－３ 및 이의 용도
US9795624B2 (en) 2015-05-04 2017-10-24 Research Foundation Of The City University Of New York Cationic polymers as co-drugs for chemotherapeutic agents
US11077187B2 (en) 2015-11-17 2021-08-03 Oklahoma Medical Research Foundation Epitope of optimized humanized monoclonal antibodies against activated protein C and uses thereof
AU2017207370B2 (en) * 2016-01-12 2021-09-23 University Of Southern California Use of long-term fasting mimicking as dietary treatment for multiple myeloma and other cancers
AU2017261723B2 (en) 2016-05-11 2023-02-09 University Of Southern California Fasting mimicking diet (FMD) as an immunoregulatory treatment for gastrointestinal autoimmune/inflammatory diseases.
US11284640B2 (en) 2017-02-14 2022-03-29 University Of Southern California Fasting mimicking diet
CA3056797A1 (en) 2017-03-16 2018-09-20 Children's Medical Center Corporation Engineered liposomes as cancer-targeted therapeutics
CN109949256B (zh) * 2019-01-14 2023-04-07 昆明理工大学 一种基于傅里叶变换的天文图像融合方法
KR20210124310A (ko) 2019-02-06 2021-10-14 벤테라, 인코포레이티드 국소 포스포이노시티드 3-키나제 억제제
JP2023535280A (ja) * 2020-07-20 2023-08-17 エフエヌシーティー バイオテック、インコーポレイテッド 大腸癌転移阻害剤をスクリーニングする方法
JP2023538265A (ja) * 2020-08-04 2023-09-07 ベンセラ，インコーポレイティド ホスホイノシチド３－キナーゼ阻害剤の製剤
KR20230107115A (ko) 2022-01-07 2023-07-14 서울대학교병원 항-icam-1 항체의 단기요법을 이용한 간이식 거부반응의 억제방법
UY40783A (es) 2023-06-12 2024-12-31 Amgen Inc Proteínas de unión a agonistas del receptor beta de linfotoxina

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
ZA883159B (en) * 1987-05-04 1990-01-31 Dana Farber Cancer Inst Inc Intercellular adhesion molecules and their binding ligands
US5643872A (en) 1989-10-23 1997-07-01 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
US6008058A (en) 1993-06-18 1999-12-28 University Of Louisville Cyclic peptide mixtures via side chain or backbone attachment and solid phase synthesis
GB9701425D0 (en) 1997-01-24 1997-03-12 Bioinvent Int Ab A method for in vitro molecular evolution of protein function
GB0525214D0 (en) * 2005-12-12 2006-01-18 Bioinvent Int Ab Biological materials and uses thereof
CN102099684A (zh) * 2008-02-29 2011-06-15 国立大学法人信州大学 前哨淋巴结内转移癌细胞检测试剂盒
GB0903151D0 (en) * 2009-02-25 2009-04-08 Bioinvent Int Ab Antibody uses and methods

Similar Documents

Publication Publication Date Title
JP2013539454A5 (enExample)
JP2012126742A5 (enExample)
CY1122278T1 (el) Αντι il-36r αντισωματα
JP2017048194A5 (enExample)
JP2011182796A5 (enExample)
JP2014518898A5 (enExample)
JP2018504907A5 (enExample)
JP2017176174A5 (enExample)
RU2018132044A (ru) Антитела против тау
JP2010227108A5 (enExample)
JP2012034696A5 (enExample)
JP2011155981A5 (enExample)
JP2012102113A5 (enExample)
UA111818C2 (uk) Антитіло проти csf-1r
JP2016525888A5 (enExample)
PH12016500859B1 (en) Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
JP2013510581A5 (enExample)
JP2014051497A5 (enExample)
JP2009225798A5 (enExample)
RU2018137842A (ru) Агонисты рецепторов глюкагона/glp-1 для лечения ожирения
JP2012136541A5 (enExample)
JP2012507294A5 (enExample)
JP2014205674A5 (enExample)
JP2014028813A5 (enExample)
JP2011219478A5 (enExample)